Li Yingying, Zhu Feng, Xu Hong, et al. Saccharomyces Boulardii in the Prevention of Antibiotics-Associated Diarrhea in Neonates. [J]. 27(7):22-25(2021)
DOI:
Li Yingying, Zhu Feng, Xu Hong, et al. Saccharomyces Boulardii in the Prevention of Antibiotics-Associated Diarrhea in Neonates. [J]. 27(7):22-25(2021) DOI: 10.13407/j.cnki.jpp.1672-108X.2021.07.007.
Saccharomyces Boulardii in the Prevention of Antibiotics-Associated Diarrhea in Neonates
Objective: To probe into the efficacy and safety of Saccharomyces boulardii in the prevention of antibiotics-associated diarrhea (AAD) in neonates. Methods: A total of 298 neonates treated with antibiotics in the neonatal ward of Suzhou Municipal Hospital of Anhui Province from Aug. 2017 to Aug. 2018 were extracted to be divided into the intervention group and the control group. In addition to intravenous antibiotics
the intervention group was given oral S. boulardii powder
0.125 g each time
twice a day
for a total of 14 d. The control group only received conventional anti-infection therapy. The incidence of AAD and changes of related indicators in both groups were observed during treatment
the frequency and duration of defecation in children with AAD were recorded. The prevention effect was evaluated according to the incidence of AAD in children of different ages. Results: During antibiotic administration
the incidence of AAD in the intervention group (11.49%) was lower than that in the control group (29.33%
P<0.01). The application time of antibiotics and length of stay in the intervention group were shorter than those in the control group (P<0.01). The average frequency of defecation and duration of diarrhea decreased in children with AAD in the intervention group compared with those in the control group on the 1st
4th and 7th d of treatment (P<0.01). The risk of AAD in children ≤7 d in the intervention group was reduced by 47% (P<0.05)
and the risk of children >7 d in the intervention group was reduced by 78% (P<0.05). Within 14 d after the withdrawal of antibiotics
the risk of AAD in children ≤7 d in the intervention group was reduced by 68% (P<0.05)
and the risk of AAD in children >7 d in the intervention group was reduced by 92% (P<0.05). Conclusion: S. boulardii can reduce the incidence of AAD and alleviate the symptoms in neonates
and its delayed protective effect is effective and safe in preventing AAD